Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypofractionated radiotherapy for Graves' orbitopathy.

R Heyd1, G Strassmann, M Herkströter

  • 1Strahlenklinik, Klinikum Offenbach, Offenbach am Main.

Rontgenpraxis; Zeitschrift Fur Radiologische Technik
|January 22, 2002
PubMed
Summary

Hypofractionated radiotherapy effectively treats severe Graves' orbitopathy, even in long-standing cases. This approach shows comparable results to conventional radiotherapy for managing this eye condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High Dose Rate Brachytherapy as Monotherapy for Localised Prostate Cancer: Review of the Current Status.

Clinical oncology (Royal College of Radiologists (Great Britain))·2017
Same author

[Not Available].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

[Not Available].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

Isothermal dehydration of thin films of water and sugar solutions.

The Journal of chemical physics·2014
Same author

Evaluation of time, attendance of medical staff, and resources during interstitial brachytherapy for prostate cancer : DEGRO-QUIRO trial.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2014
Same author

A combined silver and Sudan stain for demonstration of senile plaques and lipoids in frozen sections.

Journal of neuropathology and clinical neurology·2014

Area of Science:

  • Ophthalmology
  • Radiation Oncology

Background:

  • Graves' orbitopathy (GO) is a complex autoimmune condition affecting the eyes.
  • Radiotherapy (RT) is an established treatment for GO, typically using conventional fractionation.
  • The efficacy of hypofractionated RT for GO remains largely unexplored.

Purpose of the Study:

  • To evaluate the effectiveness of hypofractionated radiotherapy in managing severe Graves' orbitopathy.
  • To assess outcomes in patients with treatment-resistant GO previously managed with corticosteroids.

Main Methods:

  • Retrospective analysis of 33 euthyroid patients with Graves' orbitopathy.
  • Treatment involved hypofractionated RT: 21.0 Gy in 3 weekly fractions of 3.0 Gy.
  • Patients had symptom duration of 1-84 months and prior corticosteroid treatment failure.

Related Experiment Videos

  • Outcomes assessed using Donaldson criteria and a clinical classification (eyelid changes, exophthalmos, myopathy, optic neuropathy) after a mean 33.6-month follow-up.

    • Main Results:

    • Overall treatment response rate was 84.8% (28/33 patients).
    • Significant improvement observed in eyelid changes and exophthalmos (57.6%) and myopathy (36.4%).
    • Two patients (6.0%) required surgical decompression due to optic nerve compression.
    • Nine percent (9.0%) were classified as non-responders due to disease progression.

    Conclusions:

    • Hypofractionated radiotherapy is an effective treatment for severe Graves' orbitopathy, particularly in patients with prolonged symptoms.
    • Results indicate that hypofractionated RT yields outcomes comparable to conventional fractionated RT.
    • This approach offers a viable alternative for managing refractory Graves' orbitopathy.